Company: LRHC
Filing Date: 2025-03-07
Form Type: DEF 14C
Source: 0001213900-25-021334
Chunk: 33

Company: La Rosa Holdings Corp.
Filing Date: 2025-03-07
Form: DEF 14C
Chunk 33
---
 obtain the approval of the Company’s stockholders. The issuance of additional shares could result
in the dilution of the value of the shares now outstanding, if the terms on which the shares were issued were less favorable than the
contemporaneous market value of the Company’s Common Stock.

The increase in the number of shares of Common Stock available for
issuance is not being done for the purpose of impeding any takeover attempt. Nevertheless, the power of the Board of Directors to provide
for the issuance of shares of Common Stock without stockholder approval has potential utility as a device to discourage or impede a takeover
of the Company. In the event that a non-negotiated takeover was attempted, the private placement of stock into “friendly”
hands, for example, could make the Company unattractive to the party seeking control of the Company. This would have a detrimental effect
on the interests of any stockholder who wanted to tender his or her shares to the party seeking control or who would favor a change in
control.

<div align='center'>19</div>

Effective Time and Implementation of the Amendment

The effective time for the Amendment will be the date on which we file the Amendment with the office of the Secretary of State of the State of Nevada or such later date and time as specified in the Amendment. We currently anticipate that the Amendment will be effective no earlier than March 28, 2025, or twenty (20) days after this Information Statement has been made available to our stockholders, which we expect to be on or approximately March 7, 2025.

<div align='center'>EFFECTIVE DATE OF ACTION BY WRITTEN CONSENT</div>

Per Rule 14c-2 under the Exchange Act, the corporate action taken by written consent becomes effective no earlier than twenty (20) calendar days after the first mailing or delivery of this Information Statement to stockholders as of the Record Date. This Information Statement provides a comprehensive overview of the actions approved by the holders of a majority of our outstanding Common Stock.

<div align='center'>DISSENTER’S RIGHTS OF APPRAISAL</div>

Stockholders do not have any dissenter’s rights or appraisal rights in connection with the approval of the Corporate Actions described in this Information Statement.

<div align='center'>OUTSTANDING VOTING SECURITIES</div>

Each share of Common Stock grants one vote on each matter submitted
to stockholders. Each share of Series X Super Voting Preferred Stock of the Company grants 10,000